Javascript must be enabled to continue!
Effectiveness and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction
View through CrossRef
Background
Endoscopic submucosal dissection of the esophagogastric junction is the most difficult gastric and esophageal dissection procedure. No reports of endoscopic submucosal dissection for Siewert type II carcinoma of the esophagogastric junction have compared the outcomes of endoscopic submucosal dissection for all three Siewert types of adenocarcinoma. This study aimed to evaluate the efficacy and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction.
Methods
From October 2008 to June 2013, 73 patients underwent endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction. The patients were prospectively evaluated regarding the executability of the technique, short-term results of the procedure, en bloc resection rate, curative resection rate, complications and additional treatment after endoscopic submucosal dissection, and follow-up outcomes.
Results
Sixty-eight of the 73 patients (93.2%) underwent en bloc resection; the mean maximum specimen diameter was 33.7 mm. Fifty-seven of 61 patients (93.4%) who underwent curative resection were successfully followed-up for 1.0 to 56.0 months (average, 24.1 months). Local recurrence developed in one patient with high-grade intraepithelial neoplasm. Twelve patients underwent noncurative resection, including lateral resection margin residues in three, vertical resection margin residues in one, signet ring cell carcinoma or undifferentiated adenocarcinoma in four, lymphatic or vessel invasion in one, vertical residual margin residues combined with signet ring cell carcinoma in one, and undifferentiated adenocarcinoma with lymphatic or vessel invasion in two. In the noncurative resection group, one patient was lost to follow-up, seven underwent additional surgery, and the remaining four were periodically followed up; none had local recurrence or distant metastases. The only complication was delayed bleeding in three patients, which was successfully controlled by conservative treatment or endoscopic therapy.
Conclusions
Endoscopic submucosal dissection is safe and effective for intraepithelial neoplasia of the esophagogastric junction. R0 en bloc resection is possible and can avoid the risk of local recurrence.
Ovid Technologies (Wolters Kluwer Health)
Title: Effectiveness and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction
Description:
Background
Endoscopic submucosal dissection of the esophagogastric junction is the most difficult gastric and esophageal dissection procedure.
No reports of endoscopic submucosal dissection for Siewert type II carcinoma of the esophagogastric junction have compared the outcomes of endoscopic submucosal dissection for all three Siewert types of adenocarcinoma.
This study aimed to evaluate the efficacy and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction.
Methods
From October 2008 to June 2013, 73 patients underwent endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction.
The patients were prospectively evaluated regarding the executability of the technique, short-term results of the procedure, en bloc resection rate, curative resection rate, complications and additional treatment after endoscopic submucosal dissection, and follow-up outcomes.
Results
Sixty-eight of the 73 patients (93.
2%) underwent en bloc resection; the mean maximum specimen diameter was 33.
7 mm.
Fifty-seven of 61 patients (93.
4%) who underwent curative resection were successfully followed-up for 1.
0 to 56.
0 months (average, 24.
1 months).
Local recurrence developed in one patient with high-grade intraepithelial neoplasm.
Twelve patients underwent noncurative resection, including lateral resection margin residues in three, vertical resection margin residues in one, signet ring cell carcinoma or undifferentiated adenocarcinoma in four, lymphatic or vessel invasion in one, vertical residual margin residues combined with signet ring cell carcinoma in one, and undifferentiated adenocarcinoma with lymphatic or vessel invasion in two.
In the noncurative resection group, one patient was lost to follow-up, seven underwent additional surgery, and the remaining four were periodically followed up; none had local recurrence or distant metastases.
The only complication was delayed bleeding in three patients, which was successfully controlled by conservative treatment or endoscopic therapy.
Conclusions
Endoscopic submucosal dissection is safe and effective for intraepithelial neoplasia of the esophagogastric junction.
R0 en bloc resection is possible and can avoid the risk of local recurrence.
Related Results
Oligometastatic disease in esophagogastric cancer
Oligometastatic disease in esophagogastric cancer
Patients with limited metastatic esophageal or gastric cancer (oligometastatic esophagogastric cancer) may benefit from local treatment of oligometastases combined with systemic th...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract
Introduction
Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Evaluation of Postoperative Outcomes of Endoscopic Submucosal Dissection in Primary Gastric Cancer
Evaluation of Postoperative Outcomes of Endoscopic Submucosal Dissection in Primary Gastric Cancer
Background: Few studies have investigated the changes in postoperative quality of life; serum Livin, epidermal growth factor (EGF), and interleukin (IL)-8 levels; and traumatic str...
Management of Pouch Neoplasia
Management of Pouch Neoplasia
BACKGROUND:
Pouch neoplasia occurs following ileal pouch-anal anastomosis, with or without mucosectomy in ulcerative colitis and familiar adenomatous polyposis.
...
Clinico-pathologic determinants of non-e-curative outcomes following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
Clinico-pathologic determinants of non-e-curative outcomes following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
Abstract
BackgroundEndoscopic submucosal dissection (ESD) is gaining enormous popularity in the treatment of early gastric cancers (EGCs) across many institutions in the wo...
Endoscopic Submucosal Dissection in Patients with Ulcerative Colitis
Endoscopic Submucosal Dissection in Patients with Ulcerative Colitis
Patients with ulcerative colitis have an increased risk of developing colorectal cancer. This risk has been estimated to reach about 7% at 20 years of disease, 7–14% at 25 years, a...
Factors Influencing Patient Safety Management Behaviors in Nursing Students
Factors Influencing Patient Safety Management Behaviors in Nursing Students
The objective of this study is to identify the critical thinking Disposition, problem-solving processes, safety motivation, patient safety management knowledge, attitudes towards p...
Evolving field of third‐space endoscopy: Derivatives of peroral endoscopic myotomy
Evolving field of third‐space endoscopy: Derivatives of peroral endoscopic myotomy
Third‐space endoscopy, also known as submucosal endoscopy, allows for a wide range of therapeutic interventions within the submucosal layer and even into the muscular or subserosal...

